Diabetes-Metabolism Research and Reviews

Papers
(The H4-Index of Diabetes-Metabolism Research and Reviews is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
352
Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials247
The circadian syndrome is a predictor for cognition impairment in middle‐aged adults: Comparison with the metabolic syndrome151
Issue Information150
Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort141
Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking99
Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)97
The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application95
Central and Peripheral Sensitivity to Thyroid Hormones Correlate to Metabolically Obesity Phenotypes in Chinese Euthyroid Adults: A Cross‐Sectional Study84
Longitudinal cardiovascular health measured by life's essential 8 metrics with incident diabetes: A 13‐year prospective cohort study76
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis68
Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes63
Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 203562
59
Issue Information59
Determinants of Prediabetes in Adolescents: Evidence From Indonesia57
Development of a Chinese‐Specific Clinical Model to Predict Maturity‐Onset Diabetes of the Young51
Withdrawal: Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquill50
Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes49
Stuttering in adolescence and the risk for dysglycemia in early adulthood47
The relationship between neonatal hypoglycaemia and cord blood C‐peptide levels in neonates of birthing individuals with type 1 diabetes45
Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes44
Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China43
Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes41
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials39
Classification of foot ulcers in people with diabetes: A systematic review39
Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years37
37
Cover Image36
Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review35
Cost‐Effectiveness of Artificial Intelligence Assisted Screening for Diabetic Retinopathy: A Markov Model35
N‐Lactoyl Amino Acids: Emerging Biomarkers in Metabolism and Disease35
Diagnosis of infection in the foot of patients with diabetes: A systematic review34
Pep19: A Novel Approach for Reducing Visceral Fat and Improving Sleep Quality in Obese Adults—Results From an Early‐Stage Clinical Trial33
Risk of New‐Onset Ischaemic and Haemorrhagic Stroke in Patients With Type 2 Diabetes With Chronic Kidney Disease on SGLT‐2 Inhibitor Users: A Population‐Based Cohort Study33
0.21202993392944